GreenLight Biosciences Holdings
GRNA · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $65,558 | $155,731 | $322,624 | $272,382 |
| - Cash | $32,350 | $68,097 | $98,353 | $44,132 |
| + Debt | $77,425 | $80,482 | $29,681 | $31,558 |
| Enterprise Value | $110,633 | $168,116 | $253,952 | $259,808 |
| Revenue | $3,820 | $2,947 | $1,689 | $1,748 |
| % Growth | 29.6% | 74.5% | -3.4% | – |
| Gross Profit | $3,820 | $2,947 | $1,689 | $1,748 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$25,355 | -$35,191 | -$34,240 | -$50,531 |
| % Margin | -663.7% | -1,194.1% | -2,027.2% | -2,890.8% |
| Net Income | -$28,043 | -$39,979 | -$38,158 | -$51,892 |
| % Margin | -734.1% | -1,356.6% | -2,259.2% | -2,968.6% |
| EPS Diluted | -0.18 | -0.3 | -0.27 | -0.42 |
| % Growth | 40% | -11.1% | 35.7% | – |
| Operating Cash Flow | -$31,060 | -$24,589 | -$39,977 | -$22,697 |
| Capital Expenditures | -$1,608 | -$3,603 | -$10,074 | -$12,583 |
| Free Cash Flow | -$32,668 | -$28,192 | -$50,051 | -$35,280 |